Related Experiment Video

Updated: Jun 4, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer

Yuh-Pyng Sher1, Shih-Jen Liu, Chun-Mien Chang

  • 1Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.

Molecular Cancer Therapeutics
|February 2, 2011
PubMed

Insights

This study introduces SV-BikDD, a targeted gene therapy for lung cancer. It effectively kills cancer cells and stimulates an immune response, offering a promising systemic antitumoral immunity strategy.

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Metastatic lung cancer is a major cause of cancer-related deaths.
  • Targeted cancer gene therapy offers a promising treatment strategy.
  • Previous research developed a specific gene therapy system for lung cancer.

Purpose of the Study:

  • To evaluate the efficacy of SV-BikDD, a novel cancer-targeted gene therapy.
  • To assess its ability to induce both direct cytotoxic effects and an adaptive immune response.
  • To determine its potential for developing systemic antitumoral immunity against lung cancer.

Main Methods:

  • Developed SV-BikDD using the survivin promoter to drive the apoptotic gene BikDD.
  • Tested SV-BikDD in immunocompromised and immunocompetent mouse models.
  • Administered CMV-BikDD as a comparative treatment.

Main Results:

  • SV-BikDD demonstrated cancer-specific cytotoxicity and induced a cytotoxic T lymphocyte response.
  • This gene therapy established systemic antitumoral immunity against tumor rechallenges.
  • Unlike CMV-BikDD, SV-BikDD did not elicit immune responses against normal tissues.
  • SV-BikDD induced proinflammatory cytokines, activating innate immunity.

Conclusions:

  • SV-BikDD is a potent cancer-targeted gene therapy for lung cancer.
  • It synergistically combines direct tumor cell killing with the induction of robust antitumoral immunity.
  • This approach holds significant promise for clinical development in lung cancer treatment.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.